
Galimedix Therapeutics
Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing novel radiopharmaceuticals for PET imaging.
About
Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule therapies for neurodegenerative diseases. Their lead candidate, GAL-101, is in Phase 2 clinical testing for dry age-related macular degeneration (AMD), glaucoma, and Alzheimer's disease, aiming to block a key step in the neurodegenerative process with a well-tolerated compound. These therapies are designed for convenient administration as eye drops or oral tablets, serving patients and caregivers with a focus on improved tolerability.
Listed competitors
Also in this space
AI-driven digital twin of embryo development for cell-based therapies.
Shares Life Sciences, Therapeutics
Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
Shares Life Sciences, Therapeutics
AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
Shares Life Sciences, Therapeutics
AI-powered patient-centric drug simulations to accelerate and de-risk drug development.
Shares Life Sciences, Clinical Trials
Omnix Medical is developing a novel platform for advanced wound care management.
Shares Life Sciences, HealthTech
Develops a platform for individual drug customization using aptamers for cancer treatment.
Shares Life Sciences, Therapeutics
Key facts
- Website
- galimedix.com
- Headquarters
- Copenhagen, Denmark
- Founded
- 2018
- Employees
- 12
- Business model
- B2B
Tech stack
Detected on galimedix.com, last scanned 3 Nov 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Galimedix Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Galimedix Therapeutics is 85 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How many employees does Galimedix Therapeutics have?
Galimedix Therapeutics has approximately 12 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Galimedix Therapeutics:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

